Diabetes Core Update – April 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Normalization of functional beta cell capacity after weight loss in type 2 diabetes Screening for glucose intolerance and diabetes in patients with coronary artery disease Trends Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018 Impact of a Telephone Intervention to Improve Diabetes Control on Healthcare Utilization and Cost for Adults in South Bronx, New York – Efficacy and Safety of Dapagliflozin Plus Saxagliptin Versus Insulin Glargine Over 52 Weeks as Add‐on to Metformin With or Without Sulfonylurea in Patients With Type 2 Diabetes The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M...
Source: Diabetes Core Update - Category: Endocrinology Authors: Source Type: podcasts

Related Links:

Publication date: Available online 23 May 2020Source: Preventive MedicineAuthor(s): Soraya J. van Etten, Loes Crielaard, Mirthe Muilwijk, Irene van Valkengoed, Marieke B. Snijder, Karien Stronks, Mary Nicolaou
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research
TYPE 2 DIABETES is one of the underlying health conditions that make somebody more vulnerable to the effects of coronavirus. Now diabetics may face self-isolation while others are allowed to move on with their lives.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
TYPE 2 DIABETES trademark is high blood sugar levels . The daily task of diabetics is to manage their condition. Which drink may help people to do so?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
CONCLUSIONS: The STEP program evaluates the efficacy and safety of semaglutide 2.4 mg subcutaneously once weekly in a broad population. The trials will provide insights on WM in people with obesity with and without type 2 diabetes and on long-term follow-up. PMID: 32441473 [PubMed - in process]
Source: Obesity - Category: Eating Disorders & Weight Management Authors: Tags: Obesity (Silver Spring) Source Type: research
To evaluate the efficacy and safety of thrice daily Biphasic Human Insulin 30 (BHI 30) versus the traditional twice-daily regimen in type 2 diabetes mellitus (T2DM) patients. It ’s a cross over single clinical ...
Source: BMC Research Notes - Category: Research Authors: Tags: Research note Source Type: research
In current management of type 2 diabetes (T2DM), cardiovascular and renal prevention have become important targets to be achieved. In this context, a joint panel of four endocrinology societies from Brazil and...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Tags: Review Source Type: research
Although important advances in treatment strategies have been developed in type 2 diabetes mellitus (T2DM), large gaps exist in achieving glycemic control and preventing complications, particularly in low-and ...
Source: International Journal for Equity in Health - Category: International Medicine & Public Health Authors: Tags: Research Source Type: research
Publication date: Available online 22 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Victoria E. Sanborn, M. Andrea Azcarate-Peril, John Gunstad
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Nonalcoholic fatty liver disease (NAFLD) is common in older patients with type 2 diabetes. In older patients with type 2 diabetes, the presence of NAFLD is associated with a higher risk of hepatic (eg, nonalcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma) and extrahepatic (eg, cardiovascular disease, sarcopenia, and dementia) complications than that observed in other patient groups. For this reason, appropriate identification and management of NAFLD are clinically relevant particularly in the group of older patients with type 2 diabetes. In this regard, clinicians should consider the peculiar characteristi...
Source: Clinics in Geriatric Medicine - Category: Geriatrics Authors: Source Type: research
International Diabetes Federation estimates that there are more than a half-billion adults ages 20 to 79  years worldwide who have diabetes mellitus (DM) and that the global health care expenditure for adults with DM in 2015 was $673 billion. Nonadherence and nonpersistence to prescribed type 2 DM medications are common and remain a barrier to optimal health outcomes. There is a high prevalence of non adherence among older adults. Research has focused on prevalence and predictors of adherence, research methodologies, and development of measures of adherence. Improvements hopefully will result in better disease monitor...
Source: Clinics in Geriatric Medicine - Category: Geriatrics Authors: Source Type: research
More News: Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Forxiga | Health Management | Insulin | Lantus | Metformin | Podcasts | Residencies | Science | SGLT2 Inhibitors | Weight Loss